| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | ENLITE GLUCOSE SENSORS |
| Generic Name | Automated insulin dosing , threshold suspend |
| Applicant | Medtronic, Inc. 18000 Devonshire St. Northridge, CA 91325 |
| PMA Number | P120010 |
| Supplement Number | S041 |
| Date Received | 10/30/2014 |
| Decision Date | 01/28/2015 |
| Product Code |
OZO |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT01112696
|
| Supplement Type | Real-Time Process |
| Supplement Reason | Change Design/Components/Specifications/Material |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement APPROVAL FOR MINOR DESIGN CHANGES TO THE SENSOR BASE, O-RING, TAPE, ADHESIVE AND SENSOR PATCH OF THE ENLITE GLUCOSE SENSOR (MMT-7008A, MMT-7008B) IN ORDER TO SUPPORT MANUFACTURING CHANGES FROM A MANUAL ASSEMBLY PROCESS TO AN AUTOMATED ASSEMBLY LINE FOR THE ENLITE GLUCOSE SENSOR. THE ENLITE GLUCOSE SENSOR IS A COMPONENT OF THE MINIMED 530GSYSTEM. |
| Post-Approval Study | Show Report Schedule and Study Progress |
|
|